Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    YS Biopharma Co. Ltd.

    NASDAQ: YS · Real-Time Price · USD
    1.02
    0.09 (9.68%)
    At close: May 24, 2024, 10:00 PM

    YS Biopharma Income Statement

    Financials in CNY. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023
    Period Ending Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022
    Revenue
    		 164.98M 96.82M 176.27M 181.65M 194.06M 205.48M
    Cost of Revenue
    		 34.19M 17.51M 34.68M 38.53M 42.57M 51.13M
    Gross Profit
    		 130.79M 79.31M 141.59M 143.12M 151.49M 154.34M
    Operating Income
    		 -81.67M -113.2M -70.05M -48.11M -5.89M -11.95M
    Interest Income
    		 8.14M n/a n/a 6.79M n/a n/a
    Pretax Income
    		 -85.21M -105.22M -70.13M -88.13M 8.42M -18.98M
    Net Income
    		 -77.77M -104.98M -69.54M -53.08M 8.47M -19.59M
    Selling & General & Admin
    		 149.86M 114.3M 111.01M 96.5M 85.87M 96M
    Research & Development
    		 65.81M 78.21M 100.64M 97.94M 53.57M 70.29M
    Other Expenses
    		 n/a -381.93K -213K n/a -356.74K 132K
    Operating Expenses
    		 207.86M 179.36M 210.17M 224.46M 130.02M 166.08M
    Interest Expense
    		 n/a 6.9M 8.03M n/a 7.57M 7.38M
    Selling & Marketing Expenses
    		 71.48M 78.51M 79.19M 74.24M 68.65M 70.49M
    Cost & Expenses
    		 242.05M 196.87M 244.85M 262.99M 172.59M 217.21M
    Income Tax Expense
    		 7.44M -234.35K -586K 1.17M -46.38K 612K
    Shares Outstanding (Basic)
    		 93.06M 93.06M 93.06M 92.84M 92.62M 92.17M
    Shares Outstanding (Diluted)
    		 93.06M 93.06M 93.06M 92.84M 92.62M 92.17M
    EPS (Basic)
    		 -0.84 -1.13 -0.75 -0.57 0.09 -0.21
    EPS (Diluted)
    		 -0.84 -1.13 -0.75 -0.57 0.09 -0.21
    EBITDA
    		 -72.49M -98.48M -68.79M -40.32M 16M -11.61M
    EBIT
    		 -81.67M -98.32M -62.1M n/a -21.61M -4.44M
    Depreciation & Amortization
    		 9.17M 14.73M 43.28K -39.59K 122.08K 41.58K

    Add to Watchlist